B Kamm, M Kamm (2004) Principles of Biorefineries |
Этические аспекты генетической |
|
Appl. Microbiol. Biotechnol. 64, 137 |
инженерии 288 |
|
EuropaBio (2004) White Biotechnology: Gateway to a |
R Hails (2004) Bioethics for technology? Curr Opin |
|
more sustainable future |
Biotechnol. 15, 250 |
.. |
J Riese, R Bachmann (2004) Industrial Biotechnology: |
D Schulte (2000) Journalisten, Gentechnik und Offent- |
|
Turning the potential into profits. Chemical Marke- |
lichkeit. Nachr. aus der Chemie 626 |
|
ting Reporter, Dec. 1 |
PJ Dale (1999) Public reactions and scientific respon- |
|
DP Lawrence (2004) Environmental Impact Assess- |
ses to transgenic crops. Curr Opin Biotechnol 10, |
|
ment in Kirk-Othmer Encyclopedia of Chemical Tech- |
203 |
|
nology 5th edition, John Wiley & Sons, ISBN 0-471- |
RE Spier (1998) Animal and plant cell technology: a cri- |
|
4849 |
tical evaluation of the technology/ society interface. |
|
MA Paisley (2004) Biomass Energy in Kirk-Othmer En- |
J Biotechnol 65, 111 |
|
cyclopedia of Chemical Technology 5th edition, John |
B Irrgang (1997) Forschungsethik, Gentechnik und |
|
Wiley & Sons, ISBN 0-471-4849 |
neue Biotechnologie, S Hirzel, ISBN 3-8047- |
|
MA Matthews (2003) Green Chemistry in Kirk-Othmer |
1452-8 |
|
Encyclopedia of Chemical Technology 5th edition, John |
S Huttner (1995) Government, Researchers and Acti- |
|
Wiley & Sons, ISBN 0-471-4849 |
vists: The Critical Public Policy Interface in Biotech- |
|
BA Tokay (2002) Biomass Chemicals in Ullmann’s En- |
nology 2nd Edition, 459. Vol. 12, D Brauer (ed.), Wi- |
|
cyclopedia of Industrial Chemistry, 6th ed., Intersci- |
ley-VCH, ISBN 3-527-28322-6 |
|
ence-Wiley ISBN 3-527-31318-4 |
D Macer (1995) Biotechnology and Bioethics: What |
|
www.europabio.org |
is Ethical Biotechnology? in Biotechnology 2nd Edition, |
|
www.mckinsey.com/clientservice/chemicals/ |
115. Vol. 12, D Brauer (ed.), Wiley-VCH, ISBN 3-527- |
|
potentialprofit.asp |
28322-6 |
|
|
E Weise, H Friege, G Altner, P Schmitz, K Klostermaier |
|
Техника безопасности при проведении |
(1995) Ethics and Industrial Chemistry in Ullmann’s |
|
генно-инженерных манипуляций 284 |
Encyclopedia of Industrial Chemistry 5th edition B7, |
|
P Stadler, H Wehlmann (1999) Arbbeitssicherheit und |
1. Wiley-VCH, ISBN 3-527-20137-8 |
|
tlmweltschutz in Biound Gentechnik, Wiley-VCH, |
H Kepplinger, S Ehmig (1995) Press Coverage of Gene- |
|
ISBN 3-527-30005-6 |
tic Engineering in Germany: Facts, Faults and Causes |
|
M Droge, A Puhler, W Selbitschka (1998) Horizontal |
in Biotechnology 2nd Edition, 495. Vol. 12, D Brauer |
|
gene transfer as a biosafety issue: a natural pheno- |
(ed.). Wiley-VCH, ISBN 3-527-28322-6 |
|
menon of public concern. J Biotechnol 64, 75 |
http://bioethics.net/ |
|
.. |
|
|
D Brauer, M Broker, C Kellermann, E Winnacker |
|
290 |
(1995) Biosafety in rDNA Research and Production |
Патентование в биотехнологии |
|
in Biotechnology 2nd Edition, 63. Vol. 12, D Brauer |
S Farnley, P Morey-Nase, D Sternfeld (2004) Biotech- |
|
(ed.), Wiley-VCH, ISBN 3-527-28322-6 |
nology – a challenge to the patent system. Curr Opin |
|
T Medley, S McCammon (1995) Strategic Regulations |
Biotechnol. 15, 254 |
|
for Safe Development of Transgenic Plants in Bio- |
J Kaiser (2000) Muß Leben patentiert werden? Nachr. |
|
technology 2nd Edition, 197. Vol. 12, D Brauer (ed.), |
aus der Chemie 1077 |
|
Wiley-VCH, ISBN 3-527-28322-6 |
RS Crespi (2000) Genomics, proteomics and patents. |
|
R Simon, W Frommer (1993) Safety Aspects in Bio- |
Trends Biotechnol. 18, 405 |
|
technology in Biotechnology Second, Completely Re- |
E Szarka (1999) Patenting in biotechnology: a revi- |
|
.. |
ew of the 20th symposium of ECB8. J Biotechnol |
|
vised Edition, 835. Vol. 2, A Puhler (ed.), VCH Ver- |
||
lagsgesellschaft, ISBN 3-527-28312-9 |
67, 1 |
|
|
A Bieberbach (1997) Patente im Wandel. Chem. unse- |
|
Сертификация биотехнологической |
rer Zeit 31, 190 |
|
продукции 286 |
J Gresens (1996) Patents and Trade Secrets in Kirk- |
|
RG Werner (2004) Economic aspects of commercial |
Othmer Encyclopedia of Chemical Technology 4th |
|
manufacture ofbiopharmaceuticals. J Biotechnol. |
Edition 18, 61. Interscience-Wiley, ISBN 0-471- |
|
113, 171 |
52687-8 |
|
H Hasskarl, R Kretzschmar, K-J Hahn, M Zahn |
J Straus (1995) Biotechnology and Intellectual Proper- |
|
(1991) Pharmaceuticals, General Survey and Deve- |
ty in Biotechnology 2nd Edition, 281. Vol. 12, D Bra- |
|
lopment in Ullmann’s Encyclopedia of Industrial Che- |
uer (ed.), Wiley-VCH, ISBN 3-527-28322-6 |
|
mistry 5th edition A19, 273. Wiley-VCH, ISBN 3- |
J Gregersen (1995) Patent Applications for Biomedici- |
|
527-20119-X |
nal Products in Biotechnology 2th edition, 299. Vol. |
|
R Streinz (1995) Rechtliche Probleme der Novel Food |
12, D Brauer (ed.), Wiley-VCH, ISBN 3-527- |
|
Verordnung. Biologie in unserer Zeit 25, 256 |
28322-6 |
315 |
При подготовке иллюстраций материал был взят и |
273 |
F Lottspeich, Angewandte Chemie Int. Ed. Engl. |
||
переработан из следующих источников: |
|
38, 2476 (1999) |
||
9 |
R. Renneberg, Biohorizonte 1990 |
277 |
GN Stephanopoulos et al., Metabolic Engine- |
|
69 |
H Heslot, Biochimie 80: 19 (1998) |
|
ering – Principles and Methodologies, 1998 |
|
77 |
K Faber, Biotransformations in Organic Chemistry |
279 |
GN Stephanopoulos et al., Metabolic Engine- |
|
93 |
2000 |
.. |
283 |
ering – Principles and Methodologies, 1998 |
H Uhlig, Enzyme arbeiten fu r uns 1991 |
B Kamm, N Kamm, Appl. Microbiol. Biotechnol. |
|||
91 |
|
.. |
|
68: 1 (2004) |
H Uhlig, Enzyme arbeiten fu r uns 1991 |
|
|||
103 |
|
.. |
283 |
P Saling, Appl. Microbiol. Biotechnol. 64: 137 |
H Uhlig, Enzyme arbeiten fu r uns 1991 |
||||
109 |
HG Schlegel, Mikrobiologie 1992 |
|
(2004) |
|
109 |
.. |
|
289 |
D Schulte, Nachr. aus der Chemie A, 626 (2000) |
U Prave et al., Handbuch der Biotechnologie |
||||
|
1994 |
|
293 |
Ernst & Young Report Integration 2001 |
129 |
EGD Tuddenheim in Molecular Biology in Medici- |
293 |
Ernst & Young Report Focus on Fundamentals – |
|
|
ne, TM Cox, J Sinclair (ed.). 1997 |
|
The Biotechnology Report 2001 |
|
131 |
W Bode, H Renatur, Current Opinions in Structu- |
293 |
Ernst & Young Report Convergence – The Bio- |
|
|
ral Biology 1997 |
|
|
technology Report 2000 |
135 |
C Janeway, P Travers Immunobiology, 3d Edition |
293 |
Ernst & Young Report Refocus – The European |
|
|
1997 |
|
|
Perspective 2004 |
143C Janeway, P Travers Immunobiology, 3d Edition 1997
147 |
Mange, A Mange Basic Human Genetics Sinauer |
Бгодарности за предоставление фотографий |
|
|||
|
Associates 1992 |
|
|
.. |
|
|
|
|
139 S. Thude, personliche Mitteilung |
|
|||
165 |
Schenkel, Transgene Tiere, Spektrum-Verlag |
145 |
CSIRO, Clayton, Australia, cited from Science |
|||
|
1995 |
|
|
281, S.511 (1998) |
|
|
169 |
Schenkel, Transgene Tiere, Spektrum-Verlag |
147 T. Cox et al., Molecular Biology in Medicine, Plate |
||||
|
1995 |
|
|
25 (1997) |
|
|
185 |
J Black, Microbiology – Principles and Explora- |
169 |
Titelbild, Nature 300 |
(5893) (1982) |
175. |
|
|
tions, 4th Edition 1999 |
|
|
.. |
in unserer Zeit |
28, |
|
|
|
AJ Buchting, Biologie |
|||
189 |
J Black, Microbiology – Principles and Explora- |
|
S. 16(1998) |
|
|
|
|
tions, 4th Edition 1999 |
|
181 |
G Krczal, Transgene Pflanzen in der landwirtsc- |
||
189 |
J Black, Microbiology – Principles and Explora- |
|
haftlichen Produktion, Nachr Chem Tech Lab 45, |
|||
|
tions, 4th Edition 1999 |
|
|
S. 867 (1997) |
|
|
195 |
J Black, Microbiology – Principles and Explora- |
183 |
Susan Colburn/Monsanto, cited from Science |
|||
|
tions, 4th Edition 1999 |
|
|
282, S.2178 (1998) |
|
|
197 |
HG Schlegel, Mikrobiologie 1992 |
213 |
B Atkinson et al„ Biochemical Engineering and |
|||
199 |
HG Schlegel, Mikrobiologie 1992 |
|
Biotechnology Handbook (1992) |
|
||
217 |
K Buchholz, V Kasche, Biokatalysatoren und En- |
281 K. Mauch, insilico GmbH, Stuttgart |
|
|||
|
zymtechnologie 1997 |
|
|
|
|
|
225 |
R Knippers, Molekulare Genetik 2001 |
|
.. |
.. |
|
|
227 |
R Knippers, Molekulare Genetik 2001 |
Trotz sorgfaltiger Recherchen konnten moglicherweise |
||||
235 |
R Knippers, Molekulare Genetik 2001 |
nicht in jedem Fall Rechteinhaber von Abbildungen er- |
||||
239 |
|
.. |
|
|
.. |
|
T Brown, Gentechnologie fu r Einsteiger, 2. Aufla- |
mittelt werden. Sollte dem Verlag gegenuber der |
|||||
|
ge 1996 |
|
|
|
.. |
|
|
.. |
Nachweis der Rechtinhaberschaft gefuhrt werden, |
||||
245 |
|
|
|
.. |
|
|
T Brown, Gentechnologie fu r Einsteiger, 2. Aufla- |
wird die bei wissenschaftlichen Verlagen ubliche Ver- |
|||||
|
ge 1996 |
|
.. |
|
|
|
|
|
gutung gezahlt. |
|
|
||
253 |
TA Brown, Genomes 1999 |
|
|
|
|
|
255 |
TA Brown, Genomes 1999 (die genetische Karte |
|
|
|
|
|
|
.. |
|
|
|
|
|
|
fur Drosophila stammt von Arthur Sturtevant) |
|
|
|
|
|
257 |
TA Brown, Genomes 1999. Der Original-Grafik |
|
|
|
|
|
|
.. |
|
|
|
|
|
|
liegen folgende Veroffentlichungen zugrunde: Oli- |
|
|
|
|
|
|
ver etal., Nature 357, 38 (1992); San Miguel |
|
|
|
|
|
|
etal., Science 274, 765 (1996); Blattner et al., |
|
|
|
|
|
|
Science 277, 1453 (1997) |
|
|
|
317 |
|
259 |
SB Primrose, Genomanalyse 1996 |
|
|
|
||
Ectothiorhodospira 199 |
Micromonospora 52 |
|
Eimeria sp. 50 |
– purpurea 53 |
|
Endomycopsis 197 |
Monascus purpureus 16, 17 |
|
– fibuliger 108, 109 |
Mortierella isabellina 110 |
|
Erwinia herbicola 60, 61, 70 |
Mucor 194, 195 |
|
– sp. 60 |
– javanicus 75 |
|
Flavobacterium islandicum 199 |
– miehei 98, 99 |
|
– pusillus 99 |
|
|
Fusarium 14 |
– sufu 17 |
|
Fusarium graminearum 108, 109 |
Mycobacterium 72 |
|
Gallionella 199 |
– bovis 149 |
|
– leprae 193 |
|
|
Geotrichum 17 |
– tuberculosis 42, 48, 56, 150, 151, 193, 199, 263, |
|
Gluconobacter 24, 28 |
285 |
|
Haemophilus aegyptius 125 |
– tuberculosum 52, 53, 58 |
|
Mycoplasma pneumoniae 193 |
|
|
– influenzae 58, 149, 193, 231, 277 |
Mytilus edulis 68, 69 |
|
Halobacterium salinarum 68 |
Natronobacterium 199 |
|
Hansenula polymorpha 110, 111, 196, 197 |
|
|
Helicobacter pylori 58, 193, 263 |
Neisseria gonorrhoeае 52 |
|
Нerpes simplex 150, 184 |
– meningitidis 263 |
|
Histoplasma capsulatum 199 |
Nephila claviceps 68, 69 |
|
Humicola insolens 84, 92 |
Neurospora crassa 252 |
|
Klebsiella 69 |
Nitrosomonas 199 |
|
Nocardia 72 |
|
|
– aerogenes 75 |
– otitidis-caviarum 231 |
|
– pneumoniae 86, 87, 191 |
Ophiostoma piliferum 94 |
|
Kluyveromyces fragilis 75, 109 |
|
|
– lactis 75, 98, 99 |
Paecilomyces variotii 108, 109, 111 |
|
Konbu 32 |
|
|
Lactobacillus 28, 69, 186, 199, 228 |
Pediococcus sp. 17 |
|
Penicillium 16, 28, 194, 195 |
|
|
– acidophilus 18, 19 |
– camamberti 194 |
|
– bifidus 18 |
– chrysogenum 44–47, 59, 205 |
|
– brevis 18, 19 |
– citrinum 62, 63 |
|
– bulgaricus 19, 28 |
– emersonii 92 |
|
– casei 18, 19, 199 |
– griseofulvum 55 |
|
– delbrueckii 19, 28, 29 |
– notatum 194, 199 |
|
– helveticus 19 |
Phytophthora infestans 180 |
|
– leichmannii 28 |
Pichia pastoris 68, 110, 111, 126, 140, 196, 197, |
|
– salivarius 19 |
246, 247 |
|
Lactococcus 16 |
Plasmodium falciparum 150, 151, 262 |
|
– lactis 18, 19 |
Propionibacterium shermanii 60 |
|
Legionella 155 |
Proteus vulgaris 231 |
|
Leptothrix 199 |
Pseudomonas 117, 186, 199, 228, 242, 285 |
|
Leuconostoc 18 |
– aeruginosa 43, 65, 66, 199 |
|
– lactis 19 |
– cepacia 71, 76, 77 |
|
– mesenteroides 18, 19, 66, 67 |
– chloraphis 76, 77 |
|
– oenus 75 |
– denitrificans 60 |
|
Listeria monocytоgenes 18 |
– diminuta 46 |
|
Lithospermum erythrorhizon 64, 65 |
– putida 192, 193, 243 |
|
Melanocorpus sp. 84 |
– sp. 70, 71, 119, 243, 278 |
|
Pullularia 67 |
|
|
Methanopyrus 199 |
Pyrobaculum 199 |
|
Methylococcus capsulatus 111 |
Pyrococcus furiosus 105, 188, 234 |
|
Methylomonas clara 110 |
Pyrodictium brockii 199 |
319 |
Methylophilus methylotrophus 110, 111 |
– occultum 199 |